Zhejiang Huahai Pharmaceutical
Zhejiang Huahai Pharmaceutical Co Ltd is a Chinese multinational pharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of active pharmaceutical ingredients (APIs), finished prescription dosage forms, and biopharmaceuticals, prominently featuring cardiovascular medications, neurological drugs, and anti-infectives. The company operates extensive US FDA-compliant manufacturing facilities producing high-purity pharmaceutical ingredients and generic medicines supplied to global pharmaceutical corporations and healthcare markets. Its core business operations encompass API chemical synthesis, generic drug manufacturing, contract development and manufacturing organization (CDMO) services, and global wholesale distribution. Revenue is derived primarily from the global wholesale sale of active pharmaceutical ingredients and finished prescription medicines. Zhejiang Huahai Pharmaceutical holds a leading global market position in cardiovascular API manufacturing and generic drug exports. The company is headquartered in Linhai, Zhejiang Province, China, and its shares trade on the Shanghai Stock Exchange.
2 of the funds FundTelligence covers report a position in Zhejiang Huahai Pharmaceutical.
- Legal name
- Zhejiang Huahai Pharmaceutical Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Zhejiang Huahai Pharmaceutical
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)